Page last updated: 2024-08-22

Brilliant Blue and Colonic Neoplasms

Brilliant Blue has been researched along with Colonic Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cervetto, C; Di Cesare Mannelli, L; Ghelardini, C; Marcoli, M; Maura, G; Micheli, L; Zanardelli, M1

Other Studies

1 other study(ies) available for Brilliant Blue and Colonic Neoplasms

ArticleYear
Oxaliplatin evokes P2X7-dependent glutamate release in the cerebral cortex: A pain mechanism mediated by Pannexin 1.
    Neuropharmacology, 2015, Volume: 97

    Topics: Analgesics; Animals; Antineoplastic Agents; Benzenesulfonates; Carbenoxolone; Cell Death; Cell Line, Tumor; Cerebral Cortex; Colonic Neoplasms; Connexins; Glutamic Acid; Humans; Male; Nerve Tissue Proteins; Neuralgia; Organoplatinum Compounds; Oxaliplatin; Purinergic P2X Receptor Antagonists; Pyridines; Rats, Sprague-Dawley; Receptors, Purinergic P2X7; Rosaniline Dyes; Synaptosomes; Tetrazoles

2015